Results demonstrated that administration of PADF (10 mg/Kg/day) to mice with DSS chronic colitis significantly reversed the colon shortening, reduced the histological damage, neutrophil infiltration (as showed by MPO activity assay), and the production of inflammatory cytokines (IL-1β and TNF-α). This evidence concerns the gene TNF and Chronic colitis.